American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID ‐19 Pandemic: Version 2

ConclusionThese guidance statements have been generated based on review of the available literature, indicating that children with PRD do not appear to be at increased risk for susceptibility to SARS –CoV-2 infection. This guidance is presented as a “living document,” recognizing that the literature on COVID-19 is rapidly evolving, with future updates anticipated.

Source: Arthritis and Rheumatology - June 11, 2021 Category: Rheumatology Authors: Dawn M. Wahezi, Mindy S. Lo, Tamar B. Rubinstein, Sarah Ringold, Stacy P. Ardoin, Kevin  J. Downes, Karla B. Jones, Ronald M. Laxer, Rebecca Pellet Madan, Amy S. Mudano, Amy S. Turner, David R. Karp, Jay J. Mehta Tags: Full Length Source Type: research